⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2705993 | 1.00 | — | — | |
| SCHEMBL2756754 | 0.76 | — | — | |
| SCHEMBL9980223 | 0.76 | L3MBTL1 (0.31) | — | |
| SCHEMBL9980177 | 0.76 | — | — | |
| SCHEMBL18462573 | 0.76 | L3MBTL1 (0.31) | — | |
| SCHEMBL23485120 | 0.74 | L3MBTL1 (0.33) | — | |
| SCHEMBL2707422 | 0.74 | L3MBTL1 (0.33) | — | |
| SCHEMBL10052286 | 0.74 | L3MBTL1 (0.33) | — | |
| SCHEMBL20055236 | 0.73 | — | — | |
| SCHEMBL23774803 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9060971-B2 | Combination pharmaceutical agents as inhibitors of HCV replication | ENANTA PHARMACEUTICALS, INC. (US) | 2015-06-23 | — | — | US | disclosed |
| US-8623814-B2 | Antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2014-01-07 | — | — | US | disclosed |
| US-8178531-B2 | Antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2012-05-15 | — | — | US | disclosed |
| US-20110218175-A1 | ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2011-09-08 | — | — | US | disclosed |
| US-20110217261-A1 | COMBINATION PHARMACEUTICAL AGENTS AS INHIBITORS OF HCV REPLICATION | ENANTA PHARMACEUTICALS, INC. | 2011-09-08 | — | — | US | disclosed |
| US-20110206637-A1 | ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2011-08-25 | — | — | US | disclosed |